| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10919691 | Radiotherapy and Oncology | 2011 | 7 Pages |
Abstract
The nomogram for predicting IBR 10Â years after BCT includes seven factors, with young age, presence of DCIS and boost treatment as the most dominant factors. The nomogram estimates IBR and confirms the importance of a boost dose. Combined with a model to predict fibrosis published previously, the nomogram presented here may assist in decision making for individual patients.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Erik van Werkhoven, Guus Hart, Harm van Tinteren, Paula Elkhuizen, Laurence Collette, Philip Poortmans, Harry Bartelink,